Clinical trial
Oxaliplatin in Rectal Cancer
NCT00259363 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00259363 |
|---|---|
| Title | Oxaliplatin in Rectal Cancer |
| Official title | Phase I-II Study of Preoperative Oxaliplatin-FU and Radiotherapy for Patients With Rectal Cancer |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Neoplasms |
| Intervention type | Drug |
| Interventions | Oxaliplatin |
| Enrollment | 46 |
| Start date | Oct 1, 2002 |
| Primary completion | Jun 1, 2006 |
| First posted | Nov 29, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: